| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014113 |
| Receipt No. | R000016429 |
| Official scientific title of the study | Study about effect of agressive uric acid decrease treatment on left ventricular hypertrophy |
| Date of disclosure of the study information | 2014/06/01 |
| Last modified on | 2018/11/28 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Study about effect of agressive uric acid decrease treatment on left ventricular hypertrophy | |
| Title of the study (Brief title) | study about UA and LVH | |
| Region |
|
|
| Condition | |||
| Condition | LeftVentricular Hypertrophy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate effect of uric acid decrease treatment on left ventricular hypertrophy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Left Ventricular Mass |
| Key secondary outcomes | Cardiovascular event |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | LVH patients are divided into 2 groups: agressive UA decrease treatment group and standard treatment group. Patients of agressive UA decrease treatment group will have UA decrease treatment | |
| Interventions/Control_2 | Patients who are assigned as a standard therapy do not receive UA decrease treatment | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) LVH patients who are diagnosed by echocardiogram
2) Patients who ha have normal or high UA level 3) Older than 20 years old 4) Patients who consented to the study |
|||
| Key exclusion criteria | 1) Patients who has cardiomyopathy or valvular disease
2) Patients who has coronary artery diasese 3) Paitents who has congenital heart disease 4) Patients who has severe hepatic or renal diasese 5) Patinets who is taking diuretics 6) Patients who is allergic to Febxiostat 7) Pregnant or mother who is providing breast milk 8) Patients who doctor in charge diagnosed to be inappropriate for the study |
|||
| Target sample size | 240 | |||
| Research contact person | |
| Name of lead principal investigator | Hirotsugu Mitsuhashi |
| Organization | St Luke's International Hospital |
| Division name | Cardiovascular center |
| Address | 9-1 Akashi-cho, Chuo-ku, Tokyo |
| TEL | 03-3541-5151 |
| mitsuhashi3615@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Hirotsugu Mitsuhashi |
| Organization | St Luke's International Hospital |
| Division name | Cardiovascular center |
| Address | 9-1 Akashi-cho, Chuo-ku, Tokyo |
| TEL | 03-3541-5151 |
| Homepage URL | |
| mitsuhashi3615@yahoo.co.jp | |
| Sponsor | |
| Institute | Research office of Study of effect of UA decrease treatment on LVH |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Research office of Study of effect of UA decrease treatment on LVH |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 聖路加国際病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016429 |